Tag: methohexital_sodium_for_injection

Par Health Recalls Two Lots of Brevital Sodium Over Cellulose Particulate Matter

14 Oct 2026 4:46 p.m.

The nationwide recall of Brevital Sodium 500 mg/vial, distributed to wholesalers between July 2025 and May 2026, carries a risk of life-threatening adverse health consequences including pulmonary emboli.

Health Business Law Enforcement Medical Science Legal USA Social Issues Product Recall Par Health Brevital Sodium Methohexital Sodium for Injection US Food and Drug Administration Particulate Matter Rochester, Michigan Food Recalls FDA Drugs Methohexital Sodium MedWatch